APA (7th ed.) Citation

Mameri, H., Buhagiar-Labarchède, G., Fontaine, G., Corcelle, C., Barette, C., Onclercq-Delic, R., . . . Amor-Guéret, M. (2022). Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels. Cellular & Molecular Life Sciences, 79(8), 1. https://doi.org/10.1007/s00018-022-04487-9

Chicago Style (17th ed.) Citation

Mameri, Hamza, Géraldine Buhagiar-Labarchède, Gaëlle Fontaine, Céline Corcelle, Caroline Barette, Rosine Onclercq-Delic, Claire Beauvineau, Florence Mahuteau-Betzer, and Mounira Amor-Guéret. "Cytidine Deaminase Deficiency in Tumor Cells Is Associated with Sensitivity to a Naphthol Derivative and a Decrease in Oncometabolite Levels." Cellular & Molecular Life Sciences 79, no. 8 (2022): 1. https://doi.org/10.1007/s00018-022-04487-9.

MLA (9th ed.) Citation

Mameri, Hamza, et al. "Cytidine Deaminase Deficiency in Tumor Cells Is Associated with Sensitivity to a Naphthol Derivative and a Decrease in Oncometabolite Levels." Cellular & Molecular Life Sciences, vol. 79, no. 8, 2022, p. 1, https://doi.org/10.1007/s00018-022-04487-9.